News
BMY
50.45
+11.44%
5.18
Tech Stocks Slide On Earnings, US Economy Flexes Muscles, Small-Cap Rally Continues: This Week In The Markets
Shares of the Magnificent Seven companies all declined during the trading week. Alphabet Inc. Reported stronger-than-expected earnings and revenue, but missed on YouTube advertising revenue. Tesla Inc. Missed quarterly earnings forecasts, leading to the worst week of the year for the tech giant's stock. The U.S. Economy grew at an annualized pace of 2.8% in the second quarter.
Benzinga · 5h ago
Sector Update: Health Care Stocks Rise in Afternoon Trading
NASDAQ · 7h ago
Wall Street Enjoys Late-Week Rally On Benign Inflation Data, Dow Jones Eyes Best Session Of 2024, Tech Unwinding Stalls: What's Driving Markets Friday?
The Dow Jones Industrial Average surged 1.9% on Friday. In June, inflation dropped to 2.5% year-on-year, below the Fed's 2% target. The tech-heavy Nasdaq 100 rebounded from a negative weekly close. Homebuilders rose over 3% for the day, reaching all-time highs.
Benzinga · 7h ago
Why Bristol Myers Squibb Jumped Nearly 10% on Friday
Bristol Myers Squibb's stock is up 9.6% after a surprisingly strong second-quarter report. The company's newer drugs like Opdivo and Yervoy are helping to drive sales. The pharmaceutical company is still undervalued compared to its potential.
The Motley Fool · 8h ago
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Saia, Inc. Fell 18.6% to $398.01 on Friday. The company reported worse-than-expected second-quarter financial results. BurgerFi International and Windtree Therapeutics were among the stocks moving in today's mid-day session.
Benzinga · 8h ago
Bristol Myers Squibb (BMY) Q2 2024 Earnings Call Transcript
Bristol Myers Squibb (BMY 8.17%) Q2 2024 Earnings Call will be held on Thursday, July 26, 2024. The company will hold a conference call to discuss the second-quarter 2024 results. Chris Boerner, the company's chairman and chief executive officer, will be on the call.
The Motley Fool · 9h ago
Bristol-myers Squibb Co FY24 Annual Capital Expenditures Are Expected To Be About $1.4B
Benzinga · 9h ago
Crude Oil Down Over 2%; Bristol Myers Squibb Posts Upbeat Q2 Results
U.S. Stocks traded higher midway through trading on Friday. The Dow traded up 1.60% and the Nasdaq Composite gained over 100 points. Bristol Myers Squibb & Co. Posted strong second-quarter earnings and increased 2024 guidance. Asian markets closed mostly higher on Friday; European shares were also higher.
Benzinga · 9h ago
BMY Stock Earnings: Bristol-Myers Squibb Beats EPS, Beats Revenue for Q2 2024
Bristol-Myers Squibb just reported results for the second quarter of 2024. The company reported earnings per share of $2.07 and revenue of $12.20 billion. This was above the analyst estimate of $1.63 for the same period.
Investorplace · 9h ago
BMY Earnings: Bristol Myers Squibb Posts Strong Q2 Results
TipRanks · 10h ago
Norfolk Southern Posts Upbeat Earnings, Joins Newell Brands, Charter Communications, 3M And Other Big Stocks Moving Higher On Friday
Norfolk Southern Corporation shares rose 10.7% to $246.86 on Friday. The company reported better-than-expected second-quarter earnings results. The Dow Jones index gained more than 600 points in today's session. Coursera, Inc. Shares climbed 46.2% after the company beat earnings estimates.
Benzinga · 10h ago
BMY Crosses Above Key Moving Average Level
NASDAQ · 10h ago
Pre-Markets Swell, PCE Behaves, Several Q2 Beats
NASDAQ · 11h ago
Bristol-Myers (BMY) Tops on Q2 Earnings, Ups '24 EPS View
NASDAQ · 11h ago
Validea Detailed Fundamental Analysis - BMY
NASDAQ · 11h ago
Bristol-Myers Squibb Up Over 8%, on Pace for Largest Percent Increase Since October 2014 -- Data Talk
Dow Jones · 11h ago
Trending: Bristol Myers Squibb 2Q Adj EPS Beat Expectations
Dow Jones · 11h ago
4 stocks to watch on Friday: BMY, MMM and more
U.S. Stock index futures point to a higher open after latest reading on core personal consumption expenditures price index. Bristol Myers Squibb, Colgate-Palmolive, Norfolk Southern and 3M are among stocks to watch on Friday. BMY reported a beat-and-raise Q2; Colgate's organic sales jumped 9% Y/Y.
Seeking Alpha · 12h ago
Bristol-Myers Squibb Unveils Q2 2024 Financial Strategies
TipRanks · 13h ago
Bristol Myers Squibb (BMY) Q2 Earnings and Revenues Surpass Estimates
NASDAQ · 13h ago
More
Webull provides a variety of real-time BMY stock news. You can receive the latest news about Bristol-Myers Squibb Co through multiple platforms. This information may help you make smarter investment decisions.
About BMY
Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric antigen receptor (CAR-T) cell therapies. Small molecule drugs are typically administered orally in the form of a tablet or capsule, although other drug delivery mechanisms are used as well. Biologics are administered to patients through injections or by intravenous infusion. Its in-line products include Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Yervoy, Sprycel, Reblozyl, Opdualag, Abecma, Zeposia, and others. The Company's product pipeline includes Krazati, MRTX1719, RYZ101, KarXT, ORM-6151, and Repotrectinib.